Point72 Asset Management »

Revance Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7M 2.0M 0.86

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Shell Spon Ads (SHEL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Arista Networks (ANET)
Comcast Corp Cl A (CMCSA)
Boston Scientific Corporation (BSX)
M/a (MTSI)
Lumentum Hldgs (LITE)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl A (GOOGL)
ConocoPhillips (COP)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Revance Therapeutics

Graham Capital Management
Glazer Capital
Nuveen Asset Management
D. E. Shaw & Co
CNH Partners
Morgan Stanley
Jpmorgan Chase & Co
Citigroup
Amundi
Sonora Investment Management Group
BlackRock
BlackRock
Aviva
Point72 Asset Management
CSS

View all funds holding Revance Therapeutics